Under normal circumstances DNA mutations occurring in a cell are fixed by the cells own DNA repair mechanisms. These include nucleotide excision repair (NER), which removes damaged sections of DNA and replaces them with the correct sequence. In August Nature Medicine, Yuji Takebayashi and colleagues from the US National Cancer Institute, Bethesda, Maryland demonstrate a new cell-killing mechanism mediated by NER that can be exploited to improve cancer therapy (Nature Med 2001, 7:961-966).

Takebayashi et al. studied the effects of the novel anticancer drug ecteinascidin 743 (Et743), a natural product isolated from the Caribbean sea squirt (Ecteinascidia turbinate), on cells with the chromosome alterations seen in xeroderma pigmentosum — a hereditary condition in which the affected individual is chronically hypersensitive to UV light. They found that Et743 alters the NER process, and rather than repairing the damaged DNA it causes the NER machinery to...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!